Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Champions Oncology	BiomX	Checkmate Pharmaceuticals	X4 Pharmaceuticals	INmune Bio
Symbol	NASDAQ:CSBR	NYSEMKT:PHGE	NASDAQ:CMPI	NASDAQ:XFOR	NASDAQ:INMB
Price Information
Current Price	$9.84	$5.64	$6.30	$7.49	$10.05
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.8	0.6	2.0	1.8	1.5
Analysis Score	3.5	0.0	3.4	3.5	3.5
Community Score	2.2	2.9	2.5	2.8	3.3
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	3.3	1.7	0.8
Earnings & Valuation Score	1.9	0.0	0.6	1.3	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$16.00	$25.00	$24.75	$18.00	$21.20
% Upside from Price Target	62.60% upside	343.26% upside	292.86% upside	140.32% upside	110.95% upside
Trade Information
Market Cap	$131.76 million	$131.13 million	$136.24 million	$177.18 million	$150.08 million
Beta	1.2	0.48	N/A	0.53	3.01
Average Volume	30,449	25,236	47,205	113,232	264,218
Sales & Book Value
Annual Revenue	$32.12 million	N/A	N/A	N/A	N/A
Price / Sales	4.10	N/A	N/A	N/A	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$0.45 per share	$3.83 per share	N/A	$10.37 per share	$2.19 per share
Price / Book	21.87	N/A	N/A	N/A	N/A
Profitability
Net Income	$-1,980,000.00	$-20,560,000.00	$-28,290,000.00	$-52,810,000.00	$-7,680,000.00
EPS	($0.17)	($3.66)	N/A	($4.63)	($0.75)
Trailing P/E Ratio	N/A	N/A	0.00	N/A	N/A
Forward P/E Ratio	65.60	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-4.18%	N/A	N/A	N/A	N/A
Return on Equity (ROE)	-29.93%	-39.95%	N/A	-47.06%	-41.18%
Return on Assets (ROA)	-7.41%	-36.65%	-57.12%	-35.89%	-39.34%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	0.24%	N/A
Current Ratio	1.18%	13.87%	16.26%	10.19%	17.73%
Quick Ratio	1.18%	13.87%	16.26%	10.19%	17.73%
Ownership Information
Institutional Ownership Percentage	52.84%	26.78%	75.64%	67.76%	7.38%
Insider Ownership Percentage	46.80%	23.20%	N/A	4.90%	58.87%
Miscellaneous
Employees	143	95	22	72	4
Shares Outstanding	13.39 million	23.25 million	21.63 million	23.66 million	14.93 million
Next Earnings Date	7/26/2021 (Estimated)	N/A	9/17/2021 (Estimated)	7/29/2021 (Estimated)	8/4/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	INmune Bio, Inc. (NASDAQ:INMB) Given Average Recommendation of "Buy" by Analysts americanbankingnews.com - May 16 at 4:36 AM
	INmune Bio, Inc. (NASDAQ:INMB) Expected to Announce Earnings of -$0.33 Per Share americanbankingnews.com - May 13 at 9:58 AM
	INmune Bio, Inc. (INMB) CEO RJ Tesi on Q1 2021 Results - Earnings Call Transcript seekingalpha.com - May 7 at 8:03 PM
	INmune Bio (NASDAQ:INMB) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS americanbankingnews.com - May 7 at 3:46 PM
	INmune Bio, Inc. (INMB) Q1 2021 Earnings Call Transcript fool.com - May 6 at 4:34 AM
	INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business Update finance.yahoo.com - May 5 at 5:45 PM
	INmune Bio (INMB) Scheduled to Post Earnings on Wednesday americanbankingnews.com - April 29 at 8:16 AM
	INmune Bio, Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update ... apnews.com - April 28 at 12:28 PM
	INmune Bio, Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, May 5 finance.yahoo.com - April 28 at 12:28 PM
	INmune Bio (NASDAQ:INMB) Now Covered by Analysts at B. Riley americanbankingnews.com - April 27 at 9:12 AM
	What Type Of Shareholders Make Up INmune Bio, Inc.'s (NASDAQ:INMB) Share Registry? finance.yahoo.com - April 26 at 10:03 AM
	INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences Conference finance.yahoo.com - April 26 at 10:03 AM
	Zacks: Analysts Expect INmune Bio, Inc. (NASDAQ:INMB) to Post -$0.28 Earnings Per Share americanbankingnews.com - April 25 at 2:06 PM
	Research Analysts Offer Predictions for INmune Bio, Inc.'s Q1 2021 Earnings (NASDAQ:INMB) americanbankingnews.com - April 23 at 6:36 AM
	Why INmune Bio, Inc. (NASDAQ:INMB) Stock Might Be A Good Investment stocksregister.com - April 18 at 7:56 AM
	INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presentations at Two ... apnews.com - March 23 at 9:25 AM
	INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presentations at Two Upcoming Medical Meetings finance.yahoo.com - March 22 at 9:48 AM
	INmune Bio, Inc. Announces Participation at Upcoming Virtual Investor Conferences in March 2021 finance.yahoo.com - March 8 at 9:50 AM
	INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update finance.yahoo.com - March 4 at 7:55 PM
	INmune Bio, Inc. to Host Earnings Call finance.yahoo.com - March 4 at 2:55 PM
	INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4 finance.yahoo.com - February 25 at 12:57 PM
	We Think INmune Bio (NASDAQ:INMB) Can Easily Afford To Drive Business Growth finance.yahoo.com - January 25 at 8:51 AM
	Why INmune Bio Stock Soared Then Sank Today finance.yahoo.com - January 23 at 10:47 PM
	INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration ... apnews.com - January 21 at 8:08 AM
	INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial finance.yahoo.com - January 21 at 8:08 AM

Date	Company	Brokerage	Action
3/22/2021	Champions Oncology	Roth Capital	Boost Price Target
11/27/2019	Champions Oncology	Benchmark	Initiated Coverage
7/24/2019	Champions Oncology	Janney Montgomery Scott	Downgrade
2/27/2019	Champions Oncology	National Securities	Initiated Coverage
7/17/2018	Champions Oncology	Craig Hallum	Initiated Coverage
4/21/2021	BiomX	LADENBURG THALM/SH SH	Initiated Coverage
12/7/2020	BiomX	HC Wainwright	Reiterated Rating
1/9/2020	BiomX	Cantor Fitzgerald	Reiterated Rating
3/19/2021	Checkmate Pharmaceuticals	Jefferies Financial Group	Lower Price Target
9/1/2020	Checkmate Pharmaceuticals	Bank of America	Initiated Coverage
9/1/2020	Checkmate Pharmaceuticals	BMO Capital Markets	Initiated Coverage
9/1/2020	Checkmate Pharmaceuticals	BTIG Research	Initiated Coverage
3/22/2021	X4 Pharmaceuticals	Oppenheimer	Reiterated Rating
12/17/2020	X4 Pharmaceuticals	Brookline Capital Management	Initiated Coverage
11/30/2020	X4 Pharmaceuticals	B. Riley	Reiterated Rating
11/9/2020	X4 Pharmaceuticals	Canaccord Genuity	Lower Price Target
3/26/2020	X4 Pharmaceuticals	Citigroup	Lower Price Target
3/12/2020	X4 Pharmaceuticals	Cowen	Reiterated Rating
6/7/2019	X4 Pharmaceuticals	Stifel Nicolaus	Initiated Coverage
2/9/2021	INmune Bio	Maxim Group	Reiterated Rating

(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources